Your browser doesn't support javascript.
loading
Advances in Research on the circRNA-miRNA-mRNA Network in Coronary Heart Disease Treated with Traditional Chinese Medicine.
Lin, Fei; Chen, Heng-Wen; Zhao, Guo-An; Li, Yan; He, Xuan-Hui; Liang, Wan-Qian; Shi, Zhuo-Lin; Sun, Si-Yu; Tian, Pan-Pan; Huang, Ming-Yan; Liu, Chao.
  • Lin F; Department of Cardiology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, Henan, China.
  • Chen HW; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
  • Zhao GA; Department of Cardiology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, Henan, China.
  • Li Y; Department of Cardiology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, Henan, China.
  • He XH; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
  • Liang WQ; Department of Cardiology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, Henan, China.
  • Shi ZL; Department of Cardiology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, Henan, China.
  • Sun SY; Department of Cardiology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, Henan, China.
  • Tian PP; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
  • Huang MY; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
  • Liu C; Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
Article en En | MEDLINE | ID: mdl-32148552
ABSTRACT
There has been an increase in morbidity and mortality related to coronary heart disease (CHD) in China in recent years. Numerous clinical experiences and studies have shown that traditional Chinese medicine (TCM) plays an important role in the prevention, treatment, and prognosis of CHD. However, the mechanism of TCM in the treatment of CHD has not yet been elucidated. The circRNA-miRNA-mRNA network consists of miRNA that is competitively bound by circRNA, and miRNA regulates the transcription level of mRNA. Through literature review, we found that the circRNA-miRNA-mRNA network acts to contribute to certain effects to CHD such as myocardial hypertrophy, myocardial fibrosis, and heart failure. TCM contains constituents that act against CHD by antiatherosclerosis and apoptosis inhibition action, cardiac and cardiomyocyte protection, and these components also promote cell growth and protection of the vascular system by regulating miRNAs. Therefore, we consider that the circRNA-miRNA-mRNA network may be a new regulatory mechanism for the effective treatment of CHD by TCM.